Telehealth for GLP-1 medications is legal in all 50 states โ but the rules for how it works vary significantly depending on where you live. State medical board regulations, prescribing requirements, and compounding pharmacy laws all shape what you can access and how quickly you can get it.
The Federal Landscape
At the federal level, the DEA's pandemic-era telehealth flexibilities for controlled substances are the headline story. But GLP-1 medications are not controlled substances โ they're prescription medications that don't fall under DEA scheduling. This means the prescribing flexibility is broader: a licensed provider can prescribe a GLP-1 via telehealth without ever meeting you in person, in most states, as long as they hold a valid license in your state.
The Ryan Haight Act, which requires an in-person exam before prescribing controlled substances via telehealth, does not apply to GLP-1s. This is a significant distinction that many consumers don't realize.
Key Takeaway
GLP-1 medications are not controlled substances. The stricter telehealth prescribing rules you may have heard about (requiring in-person visits) generally don't apply to weight loss medications like semaglutide and tirzepatide.
State Licensing Requirements
The biggest variable is provider licensing. HHS guidance is clear: telehealth providers must be licensed in the state where the patient is located at the time of the visit. This means a doctor licensed only in California cannot prescribe to a patient sitting in Texas during their telehealth visit.
Major telehealth platforms address this by maintaining provider networks licensed across all 50 states. When you sign up, the platform routes you to a provider licensed in your state. This is why some platforms have faster response times in states where they have more providers โ and why rural patients in states with fewer telehealth-friendly providers may experience longer waits.
States With Extra Requirements
While most states allow GLP-1 prescribing via standard telehealth, some add requirements. A handful of states require a synchronous (live video or phone) visit for initial prescriptions โ asynchronous questionnaire-only evaluations may not meet the standard of care. Some states have specific informed consent requirements for telehealth encounters. Several states require that telehealth providers offer patients the option of an in-person referral.
These requirements don't prevent telehealth GLP-1 access โ they shape how platforms structure their visits. If you're required to do a video visit instead of a questionnaire-only process, that's actually a positive for care quality.
Compounding Pharmacy Shipping Rules
Even if your state allows telehealth GLP-1 prescribing, the medication still needs to physically reach you. Compounding pharmacies are regulated at the state level, and shipping rules vary. Most 503A pharmacies (patient-specific compounding) can ship within their state and to patients in states with reciprocal agreements. 503B outsourcing facilities can generally distribute across state lines, similar to manufacturers.
In practice, most major telehealth platforms use pharmacy partnerships that cover all 50 states. But if you're in a state with stricter compounding regulations, you may see slightly longer shipping times or different pharmacy sourcing.
The 503B Regulatory Shift
In April 2026, the FDA proposed removing semaglutide, tirzepatide, and liraglutide from the 503B bulks list. If finalized after the comment period (closing June 29, 2026), this would restrict large-scale compounding of these medications. 503A patient-specific compounding would remain available. This is an evolving situation โ check current status before making decisions.
Medicare and Medicaid Considerations
Medicare coverage for GLP-1 weight loss medications is expanding in 2026. The Medicare GLP-1 Bridge program, launching July 1, 2026, will provide eligible Part D beneficiaries with access to certain GLP-1 drugs through December 31, 2027. To qualify, patients need a BMI of 35 or greater and a prescription consistent with the FDA-approved label, including structured nutrition and physical activity.
Medicaid coverage varies by state. Some state Medicaid programs cover GLP-1s for weight loss; others limit coverage to diabetes indications only. Telehealth platforms focused on cash-pay compounded medications are typically separate from insurance pathways, but some platforms like Sesame Care prescribe brand-name medications that can be run through insurance.
Sesame Care
Prescribes FDA-approved brand-name GLP-1s that may be covered by insurance.
Prescribes FDA-approved brand-name medications only.
What This Means for You
The practical takeaway: if you're a U.S. resident, you can access GLP-1 medications through telehealth regardless of your state. The specific experience โ whether your initial visit is video or async, which pharmacy fulfills your prescription, and how quickly you receive it โ may vary. The major platforms have already built their operations to comply with state-by-state requirements, so the complexity is handled behind the scenes.
If you're concerned about your state's specific rules, look for platforms that explicitly list the states they serve and the type of consultation offered in each.
Care Bare Rx
Starting from $199/moAvailable in all 50 states with licensed providers matched to your location.
โ ๏ธ Compounded medications are not FDA-approved.